In this month’s column, I highlight three topics that are highly relevant to endoscopy clinical practice: colon polyp sizing, Helicobacter…
Browsing: Hot headlines in GI
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in early cancer detection, has unveiled the significant findings of its…
Alimentiv Inc., a prominent Contract Research Organization specializing in GI-related therapeutics, has announced the inclusion of new scientific advisors to…
People with precancerous colonic lesions exhibit significant differences in their gut microbiome compared to the general population, even up to…
Illumina has provided further details regarding the European Commission’s (EC) directive to reverse its acquisition of Grail, a company that…
The healthcare sector has long been familiar with mergers and acquisitions (M&A). Over time, consolidation has significantly transformed the healthcare…
Gastroenterology practices have garnered increasing interest from private equity firms over recent years, as highlighted in a May 2023 report…
Skyrizi (Risankizumab) demonstrated its non-inferiority to Stelara in achieving clinical remission at 24 weeks and its superiority in endoscopic remission…
Olympus Corporation, a leading global medical technology company, has announced the market launch of its next-generation EVIS X1™ endoscopy system.…
GastroGPT, a specialty-specific artificial intelligence (AI) model tailored for gastroenterology, has shown superior performance in key clinical tasks within the…